What is the price target for XBC stock?
12 analysts have analysed XBC.CA and the average price target is 1.4 CAD. This implies a price increase of 173.64% is expected in the next year compared to the current price of 0.51.
Xebec Adsorption Inc (XBC.CA) Forecast, Price Target & Analyst Ratings
TSX:XBC • CA9838911027
Current stock price
0.51 CAD
+0.01 (+2%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Xebec Adsorption Inc (XBC.CA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q3 / 2022
- EPS Estimate
- -CA$0.05
- Revenue Estimate
- 52.461M
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$1.40
Upside
+ 173.64%
From current price of CA$0.51 to mean target of CA$1.40, Based on 12 analyst forecasts
Low
CA$0.61
Median
CA$1.22
High
CA$3.15
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for XBC.CA. The average price target is 1.4 CAD. This implies a price increase of 173.64% is expected in the next year compared to the current price of 0.51.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
51.67%
XBC.CA was analyzed by 15 analysts. The buy percentage consensus is at 67. So analysts seem to be have mildly positive about XBC.CA.
In the previous month the buy percentage consensus was at a similar level.
XBC.CA was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-09-20 | STA Research | Maintains | Speculative Buy |
| 2022-08-12 | Raymond James Capital | Downgrade | Market Perform |
| 2022-08-12 | National Bank of Canada Financial | Downgrade | Sector Perform |
| 2022-08-12 | BMO Financial | Downgrade | |
| 2022-08-12 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-08-12 | Eight Capital | Downgrade | |
| 2022-08-12 | Cormark Securities | Downgrade | |
| 2022-07-27 | Eight Capital | Downgrade | Outperform |
| 2022-05-13 | Raymond James Capital | Downgrade | Market Perform |
| 2022-05-13 | National Bank of Canada Financial | Downgrade | Sector Perform |
| 2022-05-13 | BMO Financial | Downgrade | Market Perform |
| 2022-05-13 | TD Research | Downgrade | Hold |
| 2022-05-13 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-05-13 | Eight Capital | Downgrade | Neutral |
| 2022-04-14 | Raymond James Capital | Upgrade | Outperform |
| 2022-04-14 | Canaccord Capital | Upgrade | Hold |
| 2022-04-13 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-04-13 | Eight Capital | Initiate | Neutral |
| 2022-04-04 | Scotiabank Capital | Initiate | Hold |
| 2022-03-31 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-03-31 | TD Research | Downgrade | Hold |
| 2022-03-30 | Raymond James Capital | Initiate | Outperform |
| 2022-03-20 | Raymond James Capital | Initiate | Marker Perform |
| 2022-03-20 | Canaccord Capital | Downgrade | Hold |
| 2022-03-20 | Cormark Securities | Downgrade | Reduce |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q3 / 2022
- EPS Estimate
- -CA$0.05
- Revenue Estimate
- 52.461M
- Revenue Q2Q
- 96.44%
- EPS Q2Q
- 11.63%
- Number of Analysts
- 10
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2022 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 49.32M 144.04% | 56.52M 14.60% | 125.901M 122.75% | 196.704M 56.24% | 274.553M 39.58% | 310.727M 13.18% | 388.796M 25.12% | 491.344M 26.38% | |
| EBITDA YoY % growth | 5.96M 525.71% | -25.12M -521.48% | -13.118M 47.78% | -25.043M -90.91% | 8.462M 133.79% | 23.591M 178.79% | 36.506M 54.74% | 57.055M 56.29% | |
| EBIT YoY % growth | 4.12M 354.32% | -28.9M -801.46% | -25.284M 12.51% | -42.745M -69.06% | -2.611M 93.89% | 23.735M 1,009.18% | 58.75M 147.52% | 146.875M 150.00% | |
| Operating Margin | 8.35% | -51.13% | -20.08% | -21.73% | -0.95% | 7.64% | 15.11% | 29.89% | |
| EPS YoY % growth | N/A 270.37% | -0.30 -681.16% | -0.16 46.67% | -0.34 -111.99% | -0.07 77.91% | 0.00 95.51% | -0.01 -84.86% | -0.01 -86.71% |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 11.63% | -0.04 -302.00% | -0.03 78.96% | -0.02 86.53% | -0.01 90.48% | 0.00 100.00% | -0.01 60.00% | 0.00 100.00% | 0.00 100.00% | 0.00 | 0.00 100.00% | 0.00 |
| Revenue Q2Q % growth | 52.461M 96.44% | 60.848M 32.55% | 65.751M 59.62% | 69.929M 57.14% | 74.097M 41.24% | 69.98M 15.01% | 70.892M 7.82% | 76.018M 8.71% | 81.138M 9.50% | 86.663M 23.84% | 95.051M 34.08% | 99.132M 30.41% |
| EBITDA Q2Q % growth | -2.223M -174.00% | 256.419K -83.30% | 2.884M 127.76% | 4.197M 142.89% | 4.313M 294.00% | 6.116M 2,284.99% | 2.752M -4.55% | 6.105M 45.49% | 7.843M 81.85% | 10.13M 65.65% | 10.807M 292.66% | 12.322M 101.82% |
| EBIT Q2Q % growth | -6.743M -448.25% | -3.267M 69.27% | -808K 94.35% | 1.616M 109.20% | 3.636M 153.92% | 5.252M 260.74% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.55%
EPS Next 5 Year
14.02%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
35.60%
Revenue Next 5 Year
31.57%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
Xebec Adsorption Inc / XBC.CA Forecast FAQ
What are the consensus estimates for XBC stock next earnings?
The consensus EPS estimate for the next earnings of Xebec Adsorption Inc (XBC.CA) is -0.05 CAD and the consensus revenue estimate is 52.46M CAD.
How do analysts rate Xebec Adsorption Inc (XBC.CA)?
The consensus rating for Xebec Adsorption Inc (XBC.CA) is 51.6667 / 100 . This indicates that analysts generally have a neutral outlook on the stock.